Vedtofte, L, Bahne, E, Foghsgaard, S, Bagger, J I, Andreasen, C, Strandberg, C, Gortz, P M, Holst, J J, Gronbaek, H, Svare, J A, Clausen, T D, Mathiesen, E R, Damm, P, Gluud, L L, Knop, F K & Vilsboll, T 2020, ' One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial ', Journal of Clinical Medicine, vol. 9, no. 10, 3213 . https://doi.org/10.3390/jcm9103213 Journal of Clinical Medicine, Vol 9, Iss 3213, p 3213 (2020) Journal of Clinical Medicine Volume 9 Issue 10 Vedtofte, L, Bahne, E, Foghsgaard, S, Bagger, J I, Andreasen, C, Strandberg, C, Gørtz, P M, Holst, J J, Grønbæk, H, Svare, J A, Clausen, T D, Mathiesen, E R, Damm, P, Gluud, L L, Knop, F K & Vilsbøll, T 2020, ' One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial ', Journal of Clinical Medicine, vol. 9, no. 10, 3213 . https://doi.org/10.3390/jcm9103213